Alpharma, Inc. (NYSE: ALO), a global specialty pharmaceutical company, has an expanding branded franchise within the U.S. pain market with its KADIAN Capsules and the FLECTOR Patch 1.3%. The company is active in over 80 countries and is known throughout the world as a leading provider of pharmaceutical products for poultry and livestock. For further information, visit the Company’s web site at www.alpharma.com.
- 18 years ago
QualityStocks
Alpharma, Inc. (NYSE: ALO)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Closer to Regulatory and Commercial Milestones
Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC hydrogel-based cartilage regeneration technology toward key clinical, regulatory…
-
Wrap Technologies Inc. (NASDAQ: WRAP) Positions Non-Lethal Innovation at the Center of Public Safety Reform
WRAP offerings illustrate a broader industry trend toward building connected ecosystems rather than standalone products.…
-
Brownfield Gold Projects Could Hold an Edge in Today’s Permitting Environment
Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.…